Recommendations* or Suggestions* to be reinforced per specialty | |
---|---|
Allergist | S: Indicate exclusive breastfeeding to prevent allergy |
S: Oral LTRAs can be used for treatment of AR | |
ENT | S: Indicate exclusive breastfeeding to prevent allergy |
S: The use of intranasal GCS is suggested over the use of oral H1-antihistamines in AR treatment | |
R: Intramuscular GCS are not recommended for treatment of AR? | |
S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma. | |
Pulmonologist | S: Indicate exclusive breastfeeding to prevent allergy |
S:Infants and preschool children should avoid exposure to HDM to reduce the risk of developing HDM allergy/asthma. | |
S: Nasal washes can be indicated as an integral part of the treatment of AR. (69%) | |
S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment. | |
S: Intranasal antihistamines are suggested over IN-chromones in AR treatment | |
S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC | |
Pediatrician | S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment. |
R: The use of intranasal GCS is recommended over the use of oral LTRAs in AR treatment. | |
S: Intranasal antihistamines are suggested over IN-chromones in AR treatment | |
S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC | |
S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma. | |
GP | S: Nasal washes can be indicated as an integral part of the treatment of AR. |
S: The use of oral H1-antihistamines is suggested over the use of intranasal H1 antihistamines | |
S: Oral LTRAs can be used for treatment of AR | |
S: The use of oral H1-antihistamines is suggested over the use of oral LTRAs in AR treatment. | |
S: The use of intranasal GCS is suggested over the use of oral H1-antihistamines in AR treatment | |
R: The use of intranasal GCS is recommended over the use of intranasal H1-antihistamines and LTRAs in AR treatment | |
S: Intranasal antihistamines are suggested over IN-chromones in AR treatment | |
S: Intraocular H1-antiH be used for the treatment of ocular symptoms in patients with ARC S: In patients with AR and asthma Anti-IgE monoclonal antibodies can be used for the treatment of asthma. | |
All | S:No allergen-avoidance diets should be used in pregnant or breastfeeding women |
S: infants and pre-school children without animal dander allergy can have pets in their homes | |
S: Oral H1-antihistamines should NOT be used in preschool children with other allergic diseases for the prevention of wheezing or asthma | |
S: intranasal H1-antihistamines can be used for the treatment of AR | |
S: intranasal chromones can be used in AR treatment | |
S: Intranasal decongestant can be used for AR treatment, but only in a short cycle. | |
S: We suggest oral H1 antihistamines as regular AR treatment, not combined with decongestant | |
S: Intraocular chromones can be used for the treatment of ocular Sx in patients with ARC | |
S: In patients with AR and asthma: Oral H1 antihistamines with or without decongestants, intranasal GCS or LTRAs should NOT be used for the treatment of asthma. |